Collegium Pharmaceutical, Inc. · NASDAQ:COLL
Eventide Asset Management, LLC's stake in Collegium Pharmaceutical, Inc. fell to 4.50% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Eventide Asset Management, LLC's stake in Collegium Pharmaceutical, Inc. fell to 4.50%, 1,424,282 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 4.50%
- Shares
- 1,424,282
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Eventide Asset Management, LLC | 4.50% | 1,424,282 |
| Finny Kuruvilla, M.D. Ph. D. | 4.50% | 1,424,282 |
| Robin C. John | 4.50% | 1,424,282 |
Source
Related
- Collegium Pharmaceutical, Inc.
- Eventide Asset Management, LLC
- Collegium Pharmaceutical, Inc. shareholders
- Schedule 13G/A · Eventide Asset Management, LLC · Feb 13, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 8, 2026
- Schedule 13G · Millennium Management LLC · Aug 24, 2026
- Schedule 13G · Fuller & Thaler Asset Management, Inc. · Aug 14, 2026
- Schedule 13G · Principal Global Investors · Aug 5, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026